The Government has stated that £200 million will be spent on making NHS data more readily available for research and increasing its security and accessibility. It is hoped that this will allow the NHS to deliver innovative new treatments faster and increase diversity in clinical trials to combat existing health inequalities.In a further boost to the life sciences sector, the remaining money will be used to create a £60 million Life Sciences Innovative Manufacturing Fund (LSIMF). The ...

RQM+, the world’s leading provider of regulatory, clinical and quality solutions to the MedTech industry, today announced the appointment of Margaret Keegan as CEO. Keegan succeeds co-founder Maria Fagan, who is retiring and will join the board of directors as vice chair.

BIVDA, the UK’s leading association for in vitro diagnostic (IVD) technology and innovation, welcomes the £200 million in funding announced by BEIS and DHSC to support critical health research into diagnostics and treatment through enhanced data access and digital clinical trial services. Following on from the Medicines and Diagnostics Manufacturing Transformation Fund, a new £60 million Life Sciences Innovative Manufacturing Fund (LSIMF) will help to broaden the commercial-sca...

BIVDA welcomes today’s announcement by NHS chief executive Amanda Pritchard of a new campaign which encourages the public to get tested early if they fear they may have cancer.

 Rare Disease Day is taking place today, Monday 28 February 2022, and is an important opportunity to support people living with rare or undiagnosed conditions, and to take stock of the UK’s progress in facilitating better diagnostic approaches, charity funding and legislation to improve outcomes. On Rare Disease Day, 106 countries worldwide host more than 600 events to draw attention to these conditions and patients. Around 300 million globally are living with rare or undiagnosed dise...

The Government’s plans to establish a minimum of 100 community diagnostic centres (CDCs) across the country face major difficulties as medical leaders have warned that they lack the 6,000 staff necessary to run them. Health Minister Edward Argar has previously confirmed that CDCs will require an extra 3,500 radiographers, 2,000 radiologists and 500 senior nurses in order to operate.This news comes at a time when the NHS already faces a crippling workforce crisis, and many senior figures ar...

FluoretiQ Limited the award-winning start-up, pioneering NANOPLEX a 15-minute proprietary diagnostic platform for bacterial infections today announced the completion of a £1.1 million, pre-series A investment

Introduction to the Infection Management Coalition White Paper  www.theIMC.org The Covid-19 pandemic has made people more conscious of their personal health than ever before and has created awareness of the devastating impact that infections can have. Indeed, those living with supressed immune systems may have already been far more aware of the fatal risks posed by infection. We have all now witnessed how our individual actions can impact the health of others, and how an infectious dis...

BIVDA welcomes the Secretary of State’s acknowledgement of the importance of diagnostics during the pandemic. Diagnostic testing is fundamental to cutting waiting lists, spotting life-threatening illnesses, and ensuring the UK clears the elective care backlog rapidly and efficiently. As has been noted, currently only 75% of people needing a diagnostic test received one within six weeks – a fall from 96% before the pandemic. We are encouraged by the Secretary of State’s goa...

First of its kind coalition sees health industry, professional bodies and experts come together to holistically tackle ‘hidden pandemic’ of antibiotic resistant infections  COVID-19 has shone a light on the need to consider infection management as a whole Coined as the ‘hidden pandemic’, concerns are rising that antibiotic resistant infections are already presenting the next global health crisis A whole system approach is required for the way infection is detected, m...